Merck KGaA (OTCMKTS:MKKGY) Sees Strong Trading Volume After Strong Earnings

Key Points

• Merck KGaA shares experienced a significant increase in trading volume, up 285% from the previous session, after reporting better-than-expected quarterly earnings.
• The company's earnings per share for the quarter was $0.57, surpassing the consensus estimate of $0.51, with revenues reaching $6.11 billion against expectations of $5.34 billion.
• Merck KGaA's current stock price is $25.47, and it has a market capitalization of $16.42 billion with a P/E ratio of 12.03.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings. 546,189 shares were traded during trading, an increase of 285% from the previous session's volume of 142,039 shares.The stock last traded at $25.47 and had previously closed at $24.54.

The company reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.06. The firm had revenue of $6.11 billion during the quarter, compared to analysts' expectations of $5.34 billion. Merck KGaA had a return on equity of 9.61% and a net margin of 13.23%.

Merck KGaA Price Performance

The business has a 50-day simple moving average of $25.98 and a 200 day simple moving average of $27.30. The stock has a market cap of $16.42 billion, a P/E ratio of 12.03, a price-to-earnings-growth ratio of 1.96 and a beta of 0.91. The company has a current ratio of 1.31, a quick ratio of 0.83 and a debt-to-equity ratio of 0.23.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.